OncoMed Pharmaceuticals EPS of -$0.53

|About: OncoMed Pharmaceuticals... (OMED)|By:, SA News Editor

OncoMed Pharmaceuticals (NASDAQ:OMED): Q2 EPS of -$0.53 may not be comparable to consensus of -$0.03.

Revenue of $6M (+104.8% Y/Y) misses by $15.28M.